Yanqing Wang

ORCID: 0000-0002-3191-1179 · 4 papers in corpus
nonrandomized-trial 2024
Therapeutic advances in medical oncology ·doi:10.1177/17588359241307818

BACKGROUND: A newly generic microspheres, sustained-release formulation of triptorelin acetate 3.75 mg has been developed. OBJECTIVES: To evaluate the efficacy, pharmacokinetics, and safety of triptorelin 1-month formulation in Chinese pat…

observational 2020
Thoracic cancer ·doi:10.1111/1759-7714.13575

BACKGROUND: The management of ground-glass opacities (GGOs) depends mainly on personal experience. In clinical practice, benign GGOs are not rare in resected specimens, for which operations may be avoided. We retrospectively compared the cl…

lab-animal 2020
Molecular medicine reports ·doi:10.3892/mmr.2020.11564

Pelvic organ prolapses (POP) notably reduces the quality of life in elderly populations due to bladder and bowel dysfunction, incontinence, and coital problems. Extracellular matrix (ECM) disorder is a pivotal event in the progression of PO…

other 2019
Experimental and therapeutic medicine ·doi:10.3892/etm.2019.8214

Endometriosis is a common gynecological disease characterized by the presence and growth of endometrial tissue outside the uterus, including the pelvis and abdominal cavity. This condition causes various clinical symptoms, such as non-menst…